Dr. Peter Kecskemethy is a serial entrepreneur and the CEO and Co-founder of Kheiron Medical, an AI cancer diagnostics company based in London. Kheiron’s mission is to make cancer a routinely manageable disease and its current focus is breast screening. In 2023, Kheiron’s ground-breaking work and patient impact were featured on the front cover of the New York Times. Prior to Kheiron, Peter founded two tech start-ups and was tech lead in two others. He is a computer scientist, and did his PhD and post-doctoral research at the University of Oxford in high performance computing and computational statistics for population genetics.